Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Neuravi, Ltd. — Predicate Candidate Screening
4 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K212908 | EmboTrap II Revascularization Device, EMBOTRAP III Revascula | Neuravi, Ltd. | 2021-10-13 | 30 | 0 |
| K211338 | EMBOTRAP III Revascularization Device | Neuravi, Ltd. | 2021-07-30 | 88 | 0 |
| K193063 | EMBOTRAP III Revascularization Device | Neuravi, Ltd. | 2020-07-14 | 253 | 0 |
| K173452 | EmboTrap ll Revascularization Device | Neuravi, Ltd. | 2018-05-09 | 184 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda